A study to determine effective and tolerable titration scheme for OROS-Methylphenidate in Children with Attention-deficit hyperactivity disorder

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-001070-18

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of the study is to investigate the clinical benefit of switching children with ADHD from immediate-release methylphenidate (IR-MPH) to OROS-methylphenidate under the correct dosage conversion scheme.


Critère d'inclusion

  • Attention Deficit Hyperactivity Disorder

Liens